Bromide

Bromide

SCHEMBL359338

CCCCCC[N+]12CCN(CC1)CC2.[Br-]

nearest known ligand 0.35

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.35
THRB P10828 1/20 0.35
GNAI3 P08754 2/20 0.33
GNAO1 P09471 2/20 0.33
GNAI1 P63096 2/20 0.33
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
ALOX15 P16050 1/20 0.32
ALOX12 P18054 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HIF1A Q16665 1/20 0.32
HSD17B10 Q99714 1/20 0.32
DNM1 Q05193 3/20 0.30
SLC10A2 Q12908 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3239761 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL841580 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL4059880 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL4062252 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL4058133 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL4067401 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL840549 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
SCHEMBL14380155 0.98 TSHR (0.36) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL3245280 0.96 GNAI3 (0.36) TSHRTHRBGNAI3GNAO1GNAI1
Hydrochloric Acid SCHEMBL5350258 0.96 GNAI3 (0.36) TSHRTHRBGNAI3GNAO1GNAI1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10750746-B2 Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2020-08-25 US disclosed
US-20190116797-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY(PHENYLENE ETHYNYLENES) (PPEs) UNIV FLORIDA (US) 2019-04-25 US disclosed
US-10174042-B2 Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs) STC.UNM (US) 2019-01-08 US disclosed
US-10092000-B2 Structure, synthesis, and applications for oligo phenylene ethynylenes (OPEs) STC.UNM (US) 2018-10-09 US disclosed
US-10058099-B2 Antimicrobial materials and methods STC.UNM (US) 2018-08-28 US disclosed
US-20170164614-A1 ANTIMICROBIAL MATERIALS AND METHODS UNIV FLORIDA (US) 2017-06-15 US disclosed
US-20170057970-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPEs) WHITTEN DAVID G (US) 2017-03-02 US disclosed
US-9549549-B2 Antimicrobial materials and methods STC.UNM (US) 2017-01-24 US disclosed
US-9527806-B2 Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs) STC.UNM (US) 2016-12-27 US disclosed
US-20140242148-A1 ANTIMICROBIAL MATERIALS AND METHODS UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2014-08-28 US disclosed
US-20130273800-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR OLIGO PHENYLENE ETHYNYLENES (OPEs) OFFICE OF TECHNOLOGY LICENSING (US) 2013-10-17 US disclosed
US-20130210828-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPEs) UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. 2013-08-15 US disclosed
WO-2013020096-A2 ANTIMICROBIAL MATERIALS AND METHODS STC.UNM (US) 2013-02-07 WO disclosed
WO-2012009472-A2 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR OLIGO PHENYLENE ETHYNYLENES (OPES) STC.UNM (US) 2012-01-19 WO disclosed
WO-2012009484-A2 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPES) STC.UNM (US) 2012-01-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10174042-B2 Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs) PGLS, POLI, PARN TSHR 4142/4885THRB 4556/4885GNAI3 4303/4885
US-20130210828-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPEs) PGLS, POLI, PARN TSHR 4142/4885THRB 4556/4885GNAI3 4303/4885
US-20190116797-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY(PHENYLENE ETHYNYLENES) (PPEs) PGLS, POLI, PARN TSHR 4150/4885THRB 4557/4885GNAI3 4305/4885
US-20170057970-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR POLY (PHENYLENE) ETHYNYLENES (PPEs) PGLS, POLI, PARN TSHR 4142/4885THRB 4556/4885GNAI3 4303/4885
US-10092000-B2 Structure, synthesis, and applications for oligo phenylene ethynylenes (OPEs) POLI, EIF2AK2, MAVS TSHR 4239/4885THRB 4450/4885GNAI3 4399/4885
US-20130273800-A1 STRUCTURE, SYNTHESIS, AND APPLICATIONS FOR OLIGO PHENYLENE ETHYNYLENES (OPEs) POLI, EIF2AK2, DPP8 TSHR 4474/4885THRB 4558/4885GNAI3 4319/4885
US-20170164614-A1 ANTIMICROBIAL MATERIALS AND METHODS AOC3, OGFOD1, DDT TSHR 3574/4885THRB 4033/4885GNAI3 3020/4885
US-20140242148-A1 ANTIMICROBIAL MATERIALS AND METHODS AOC3, OGFOD1, DDT TSHR 3574/4885THRB 4033/4885GNAI3 3020/4885
US-10058099-B2 Antimicrobial materials and methods AOC3, OGFOD1, DDT TSHR 3574/4885THRB 4033/4885GNAI3 3020/4885
US-10750746-B2 Structure, synthesis, and applications for poly (phenylene) ethynylenes (PPEs) PGLS, POLI, PARN TSHR 4142/4885THRB 4556/4885GNAI3 4303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.